US FDA approves Astellas drug for leaky bladder
WASHINGTON, June 28
WASHINGTON, June 28 (Reuters) - U.S. drugs regulators gave the nod to Astellas Pharma Inc's pill for overactive bladder on Thursday, boosting the Japanese drugmaker's foothold in the market for the condition.
The Food and Drug Administration approved the once-daily pill, mirabegron, for adults who cannot control their bladder muscles, following a positive recommendation from FDA advisers.
DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.